SEI Investments
TVTX icon

SEI Investments’s Travere Therapeutics TVTX Stock Holding History

SEI Investments’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Buy
166,477
+32,882
+25% +$983K ﹤0.01% 1543
2025
Q4 		$5.1M Buy
133,595
+84,163
+170% +$2.74M 0.01% 1362
2025
Q3 		$1.18M Sell
49,432
-30,710
-38% -$577K ﹤0.01% 1909
2025
Q2 		$1.19M Buy
80,142
+47,730
+147% +$791K ﹤0.01% 1848
2025
Q1 		$581K Buy
32,412
+1,607
+5% +$32.6K ﹤0.01% 2094
2024
Q4 		$537K Buy
30,805
+213
+0.7% +$3.77K ﹤0.01% 2165
2024
Q3 		$428K Buy
30,592
+16,366
+115% +$171K ﹤0.01% 2234
2024
Q2 		$117K Buy
+14,226
New +$95.8K ﹤0.01% 2513
2021
Q2 		– Sell
-8,025
Closed -$219K – 2637
2021
Q1 		$219K Sell
8,025
-5,844
-42% -$161K ﹤0.01% 2363
2020
Q4 		$378K Sell
13,869
-36,513
-72% -$852K ﹤0.01% 2106
2020
Q3 		$930K Buy
+50,382
New +$979K ﹤0.01% 1633
2019
Q2 		– Sell
-584
Closed -$16K – 2767
2019
Q1 		$16K Sell
584
-133
-19% -$2.94K ﹤0.01% 2770
2018
Q4 		$19K Buy
717
+100
+16% +$2.49K ﹤0.01% 2502
2018
Q3 		$17K Sell
617
-4,543
-88% -$130K ﹤0.01% 2392
2018
Q2 		$141K Buy
+5,160
New +$137K ﹤0.01% 2171
2016
Q2 		– Sell
-400
Closed -$5K – 2754
2016
Q1 		$5K Buy
+400
New +$6.07K ﹤0.01% 2283
2015
Q4 		– Sell
-16,703
Closed -$338K – 2689
2015
Q3 		$338K Buy
+16,703
New +$495K ﹤0.01% 1437

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SEI Investments's TVTX Position: Q1 2026 in Review

SEI Investments increased its Travere Therapeutics (TVTX) stake by 25% in Q1 2026, buying an estimated $983K and bringing the position to 166,477 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

SEI Investments first reported a position in TVTX in Q3 2015 and has held it in 17 quarters since. The position peaked at $5.1M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • SEI Investments held 166,477 shares of Travere Therapeutics worth $4.95M as of Q1 2026.
  • SEI Investments bought 32,882 Travere Therapeutics shares in Q1 2026, an estimated $983K.
  • Travere Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #1543 holding.
  • SEI Investments first reported a position in Travere Therapeutics in Q3 2015 and has held it in 17 quarters since.
  • SEI Investments's Travere Therapeutics position peaked at $5.1M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.